Ropsacitinib (PF-06826647)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2127109-84-4
Tyk2-IN-8, compound 10
C18274-10mM/1mL
JAK
Angiogenesis
CN1C=C (C=N1) C2=CN3C (=CC=N3) C (=N2) C4=CN (N=C4) C5 (CC (C5) C#N) CC#N
C20H17N9
Ropsacitinib (PF-06826647, Tyk2-IN-8, compound 10) is a selective and orally administered inhibitor of tyrosine kinase 2 (TYK2) with IC50 of 17 nM for binding to TYK2 catalytically active JH1 domain. PF-06826647 (Tyk2-IN-8, compound 10) also inhibits JAK1 and JAK2 with IC50 of 383 nM and 74 nM, respectively. PF-06826647 (Tyk2-IN-8, compound 10) is used in the treatment of psoriasis (PSO) .
3 years -20°C powder
Beschrijving
Ropsacitinib (PF-06826647) Beschikbaar in 10 mM / 1 mL. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
BioCoupler® x 12
BC12
12 Each
Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03Low – 10 mg
10 mg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03High – 10 mg
10 mg
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Disc Membrane Hydrophobic PTFE, 0.22μm
CPTB14222
50 PCS
Rat Serum Albumin
CSB-NP000101r-01
1 mg
Denhardt's Solution (50X)
EC-915
50 mL
